Fidaxomicin "chaser" regimen following vancomycin for patients with multiple clostridium difficile recurrences

Clinical Infectious Diseases

Volumn 56, Issue 2, 2013, Pages 309-310

  Johnson, Stuart ^a,b   Gerding, Dale N ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIDAXOMICIN; IMMUNOGLOBULIN; LEVOFLOXACIN; METRONIDAZOLE; RIFAXIMIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LETTER; LOW DRUG DOSE; MAINTENANCE CHEMOTHERAPY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DRUG ADMINISTRATION SCHEDULE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; RECURRENCE; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84871740349     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis833     Document Type: Letter

References (6)

1. Cornelly OA, Miller MA, Louie TJ, Crook DWGorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxo-micin versus vancomycin. Clin Infect Dis 2012; 55(suppl 2):S154-61.
2. Bartlett JG, Chang T, Taylor NS, Onderdonk AB. Colitis induced by Clostridium difficile. Rev Infect Dis 1979; 1:370-8.
3. Johnson S, Schriever CA, Galang MA, Ciaran Kelly CP, Gerding DN. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007; 44:846-8. (Pubitemid 46365312)
4. Johnson S, Schriever C, Patela U, Patel T, Hecht DW, Gerding DN. Rifaximin redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment. Anaerobe 2009; 15:290-91.
5. Louie TJ, Miller MA, Mullane KM, et al. Fidax-omicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364:422-31.
6. Cornely OA, Crook DW, Esposito R, et al.; for the OPT-80-004 Clinical Study Group. Fi-daxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis 2012; 12:281-9.